Last reviewed · How we verify
NCT05225441: EnCLASS-FSEF
National Investigation in College and High School Among Adolescents on Health and Substances at the FSEF
trial in Psychiatric Disorder in 598 participants. Completed in 24 June 2022.
24 June 2022
Quick facts
| Lead sponsor | Fondation Santé des Étudiants de France |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 598 |
| Start date | 1 March 2022 |
| Primary completion | 24 June 2022 |
| Estimated completion | 24 June 2022 |
| Sites | 1 location across France |
Conditions studied
- Psychiatric Disorder — all drugs for Psychiatric Disorder →
- Somatic Symptom — all drugs for Somatic Symptom →
- Traumatic Injury — all drugs for Traumatic Injury →
Sponsor
Fondation Santé des Étudiants de France
Who can join
Adults 11 to 20, any sex, with Psychiatric Disorder or Somatic Symptom. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
For the clinical component: Describe the young people hospitalised in residential care at the FSEF, in particular through vulnerability factors and their psychosocial repercussions (school level, repetition, intensity of symptoms, irritability, nervousness, substance use (cannabis, alcohol, tobacco), social relationships, family relationships, well-being, level of health literacy, learning disorders)) and to compare them with young people from the general school population. For the epidemiological aspect: To study the construct validity of the EnCLASS questions aiming to characterize handicap situations in the general school population in both a population in situation of psychic handicap and of somatic handicap.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05225441
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Psychiatric Disorder
Currently open trials in the same condition.
- NCT07282158 — Adapted Helping Ovarian Cancer Patients Cope Intervention to Address Burnout for Gynecologic Oncology Clinicians · NA · recruiting
- NCT06977503 — Electrotherapy Stimulation Together With Life Coaching for the Support of Burnout Symptoms in Healthcare Workers · NA · recruiting
- NCT07354633 — Full Sail Ahead, Sailing in Psychosocial Rehabilitation. · NA · recruiting
- NCT07053098 — External Facilitation to Increase Prescribing of AUD Medications in the Psychiatric Setting · NA · recruiting
- NCT06376734 — Search for Novel Transcranial Magnetic Stimulation (TMS) Targets for Mental Illness · Phase 2 · recruiting
Other Fondation Santé des Étudiants de France trials
Trials by the same sponsor.
- NCT07476131 — Psychiatric Care and Education for Adolescents and Young Adults in the Ile-de-France Region: Expectations and Experience · not yet recruiting
- NCT07186335 — Effectiveness of Promoting the Role of General Practitioners in a Mental Health Care System Integrated With Primary Care · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05225441 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Fondation Santé des Étudiants de France
- Last refreshed: 26 July 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05225441.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing